October 05, 2026 07:48 pm (IST)

Make this your homepage

Health

'If law wasn't followed, we can undo it': Supreme Court's big warning on SIR process amid Gyanesh Kumar row | From TMC Rajya Sabha MP to BJP nominee in 6 months: Koel Mallick's stunning political U-turn | ‘Stomp on your head’: Omani flydubai co-pilot’s chilling posts on violence against women surface | Asian Games 2026: India beat Pakistan to clinch gold in men's cricket | flydubai cockpit attack: Deleted posts expose Omani co-pilot’s views on women, alleged extremist past | flydubai cockpit horror: Omani co-pilot Hamam al-Hammami attacked Captain Smit Machchhar with crash axe, tried to seize control | flydubai temporarily suspends all Israel flights after co-pilot’s alleged cockpit attack, crash attempt | Grounded in Oman over ‘radical views’, then hired by flydubai: What we know about Omani pilot Hamam al-Hammami | ‘Hanuman Chalisa gave me courage’: Smit Machchhar recounts flydubai cockpit battle to PM Modi | PM Modi speaks to Flydubai pilot Smit Machchhar who foiled crash plot, praises his courage

Covaxin

Image tweeted by @IndianEmbassyTR

Covaxin overall 77.8% effective against COVID-19, claims Bharat Biotech

IBNS | @indiablooms | Jul 03, 2021, at 06:54 pm

New Delhi/IBNS: Hyderabad-based biotechnology company Bharat Biotech has claimed its anti-COVID-19 vaccine, Covaxin, is 77.8% effective against the deadly virus.

Bharat Biotech made the claim in the phase three clinical trial data of the vaccine.

The company has further claimed Covaxin is 93.4% effective against severe symptomatic COVID-19 cases, 63.6% against asymptomatic COVID-19 cases and 65.2% against the Delta variant.

COVAXIN® Proven SAFE in India's Largest Efficacy Trial. Final Phase-3 Pre-Print Data Published on https://t.co/JJh9n3aB6V pic.twitter.com/AhnEg56vFN
— BharatBiotech (@BharatBiotech) July 2, 2021

Bharat Biotech co-founder Suchitra Ella tweeted, "We are proud to put India on the global map with scientific conviction,competence & commitment. #Covaxin scores #10 world class publications endorsing Innovation, clinical research,data,safety, efficacy. Thanq collaborators & Positive BB teamwork enduring a pandemic."

We are proud to put India on the global map with scientific conviction,competence & commitment. #Covaxin scores #10 world class publications endorsing Innovation, clinical research,data,safety, efficacy. Thanq collaborators & Positive BB teamwork enduring a pandemic 😇👏🏼👍🏼💉🇮🇳🙏🏼 https://t.co/c5f43WOAbQ
— suchitra ella (@SuchitraElla) July 2, 2021

At present four anti-COVID-19 vaccines including Covaxin have been permitted by the central government to be used in the vaccination drive.

Apart from Covaxin, three other vaccines are AstraZeneca's Indian version Covishield, Russia's Sputnik and US-made Moderna.

#COVID19 #BharatBiotech #Covaxin #DeltaVariant

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.